Search results for: Value-Based Pricing
Filter search results
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
…follow. Whatever people’s thoughts on the aggregate level of impact on innovation, what seems certain is that some technology types or disease areas will be impacted more than others, based…
The Dynamics of Drug Shortages
9 January 2024
…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…
Dilek Sernur Eminoğulları
26 January 2024
…policy formulation regarding pharmaceutical reimbursement, economic evaluation of drugs applying for reimbursement, drafting alternative reimbursement agreements, analysis of innovative pharmaceutical pricing and reimbursement models. She took active role in the…
OHE’s contribution to health economics
1 May 2023
…and constellation.” He has particularly valued the OHE’s work on quality assurance and particular healthcare applications. “Anything to do with pharmaceuticals or that end of medical technology — it was…
Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?
12 April 2024
…surprises in the European Parliament’s proposal beyond the scope of the regulatory protection matters we discuss in this Article, including calls for more coordination and cross-border agreements on pricing and…
Paul Oyalo
12 August 2024
…the treatment of the rare adult-onset dermatomyositis in UK population. Paul’s research interests are in cost effectiveness modelling, the economic evaluation of rare diseases, and pricing strategies for innovative therapies….
Green Healthcare: Are We Asking the Right Questions?
11 September 2024
…barrier in itself due to the long and complicated processes. The panel stressed the value of support and examples of critical success factors when making systemic policy transitions. Whilst research…
Drug shortages are on the rise – but what is their impact?
16 September 2024
…shortages, more patients being able to switch to alternative trastuzumab products, and a lower threshold applied for the “value of a QALY” in the EU. A shortage of Statins would…
Brittany Darrow
2 October 2024
…particularly interested in rare diseases and the impact of pricing and payment models on innovation and health system sustainability. She is a member of OHE’s economics of innovation (EoI) theme. …